Clinical Trials on Vaginal Flora in Sweden

Total 31 results

Region Skane
Lund University

Completed

Probiotics Against Pathogenic Bacteria in Advanced ENT-Surgery

Advanced ENT Surgery | Microbiological Flora in the Oropharynx and Lower Airways

Sweden
Pfizer

Completed

A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

Pharmacokinetics | Safety | Open Label | CAZ-AVI | CXL | Effect on Intestinal Flora

Sweden
Uppsala University

Completed

Rectovaginal Fistula Repair

Fistula;Rectal | Fistula Vagina

Sweden
Karolinska Institutet

Completed

MISOBEST - Orally Misoprostol Solution (Cytotec®) Versus Orally Misoprostol as a Tablet (Angusta®) for Induction of Labor

Induced Vaginal Delivery

Sweden
PepTonic Medical AB

Completed

Evaluation of VagiVital® for Treatment of Vaginal Atrophy

Vaginal Atrophy

Sweden
PepTonic Medical AB
StatCons; Karolinska Trial Alliance

Recruiting

Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis

Vaginal Candidiasis | Candidal Vulvovaginitis | Vulvovaginal Candidiasis

Sweden
PepTonic Medical AB
Pharma Consulting Group AB

Completed

Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women (OXYPEP002)

Vaginal Atrophy

Sweden
PepTonic Medical AB

Completed

A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

Vaginal Atrophy

Sweden
PepTonic Medical AB

Completed

Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women

Vaginal Atrophy | Postmenopause

Sweden, United Kingdom
Sahlgrenska University Hospital, Sweden

Completed

Prospective Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of Two Surgical Methods

Vaginal Vault Prolapse

Sweden
Helsingborgs Hospital
The Stig & Ragna Gorthon Foundation, Helsingborg

Completed

The Swedish Birth Seat Trial

Maternal Blood Loss | Instrumental Vaginal Births | Oxytocin Augmentation for Labor | Perineal Outcomes | Fetal Outcomes

Sweden
Karolinska Institutet

Recruiting

A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis

Candidiasis, Vulvovaginal

Sweden
Skaraborg Hospital

Completed

Diagnosis of Bacterial Vaginosis Comparing Modified Hay/Ison With Molecular Diagnosis

Infection, Bacterial

Sweden
Skaraborg Hospital

Completed

Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida

Bacterial Vaginosis

Sweden
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis

Bacterial Vaginosis

Sweden
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Sweden
ITF Research Pharma, S.L.U.
Spanish Breast Cancer Research Group

Completed

A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting (BLISSAFE)

Vaginal Atrophy

Spain, Sweden
Pharmiva AB
CPS Research; Scandinavian Development Services AB; Key2Compliance AB

Active, not recruiting

Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

Bacterial Vaginosis | Vaginal | Microbiology

Sweden, United Kingdom
Novo Nordisk A/S

Completed

Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis

Menopause | Postmenopausal Vaginal Atrophy

France, Finland, Sweden, Denmark, Norway, Hungary, Czech Republic
ITF Research Pharma, S.L.U.

Completed

Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

Vaginal Atrophy

Spain, Czechia, Hungary, Italy, Sweden
Gedea Biotech AB

Completed

Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis (Nefertiti)

Bacterial Vaginosis

United Kingdom, Sweden
Gedea Biotech AB

Completed

Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis (EpHect)

Vulvovaginal Candidiasis

Sweden
Gedea Biotech AB

Recruiting

A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group (Nefertiti 2)

Bacterial Vaginosis

Sweden
Pharmiva AB
Key2Compliance; Replior AB

Completed

A User Study With Vernivia® for Bacterial Vaginosis. (USV01)

Bacterial Vaginoses

Sweden
Dr. August Wolff GmbH & Co. KG Arzneimittel
Bremer Pharmacovigilance Service GmbH; PHARMALOG Institute for Clinical Research

Completed

Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis

Vaginosis, Bacterial

Germany
International Extranodal Lymphoma Study Group (IELSG)

Recruiting

Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients (RITZ)

Splenic Marginal Zone Lymphoma

Spain, Denmark, France, Norway, Switzerland, Sweden, Italy
Karolinska Institutet
The Swedish Society of Medicine; The regional agreement on medical training... and other collaborators

Completed

Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse

Vaginal Prolapse

Sweden, Norway, Denmark, Finland
Incyte Corporation

Active, not recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)

Follicular Lymphoma | Marginal Zone Lymphoma

Finland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
Genmab
AbbVie

Active, not recruiting

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (EPCORE™ NHL-1)

Small Lymphocytic Lymphoma (SLL) | DLBCL | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | MCL | Marginal Zone Lymphoma (MZL) | High-grade B-cell Lymphoma (HGBCL) | FL

Korea, Republic of, United States, Australia, Singapore, Netherlands, Sweden, France, Finland, United Kingdom, Spain, Germany, Denmark, Italy, Poland, Canada
Loxo Oncology, Inc.
Eli Lilly and Company

Active, not recruiting

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

B-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
BeiGene

Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Follicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | B-cell Malignancy

United States, Spain, Italy, Australia, France, Korea, Republic of, United Kingdom, Canada, Brazil, Georgia, Sweden, Germany, Moldova, Republic of

Clinical Trials on Vaginal Flora in Sweden

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations